Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Cortical Myoclonus During Lithium Exposure
Arch Neurol 60:401-404, Caviness,J.N.,&Evidente,V.G.H., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Smallpox and Smallpox Vaccination
Neurol 60:1241-1245,1228, Booss,J. &Davis,L.E., 2003
Outcome of Trigeminal Nerve Section in the Treatment of Chronic Cluster Headache
Neurol 60:1360-1362, Jarrar,R.G.,et al, 2003
Amnesia, Cerebral Atrophy, and Autoimmunity
Lancet 361:1266, Schott,J.M., et al, 2003
Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults
Arch Neurol 60:504-509, DeStefano,F.,et al, 2003
Smallpox, Bioterrorism, and the Neurologist
Arch Neurol 60:489-494, Cleri,D.J.,et al, 2003
Why Headache Treatment Fails
Neurol 60:1064-1070, Lipton,R.B.,et al, 2003
Late Onset Laryngeal and Facial Pain in Previously Asymptomatic Vagus Nerve Stimulation Patients
Neurol 60:1214, Shih,J.J.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003
Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003
Rasmussen's Encephalitis
Neurol 60:422-425, Granata,T.,et al, 2003
Early and Late Seizures After Cryptogenic Ischemic Stroke in Young Adults
Neurol 60:400-404,365, Lamy,C.,et al, 2003
Outcome in Psychogenic Nonepileptic Seizures: 1 to 10-Year Follow-up in 164 Patients
Ann Neurol 53:305-311,285, Reuber,M.,et al, 2003
Alcohol Consumption and Risk of Stroke
JAMA 289:579-588, Reynolds,K.,et al, 2003
Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Stroke 34:379-386, Bak,S.,et al, 2003
An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Treatment of Sporadic Hemiplegic Migraine with Calcium-Channel Blocker Verapamil
Neurol 60:120-121, Yu,W. &Horowitz,S.H., 2003
Clinicopath Conf,Classic Polyarteritis Nodosa Associated with Hepatitis B Infection
NEJM 348:333-342, Case 3-2003, 2003
Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker
JAMA 289:65-69, Tronvik,E.,et al, 2003
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003
Diagnostic Accuracy of Stroke Referrals from Primary Care, Emergency Room Physicians, and Ambulance Staff Using the Face Arm Speech Test
Stroke 34:71-76, Harbison,J.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
An Unconsious Girl with Sickle-Cell Disease
Lancet 361:136, van Mierlo,T.D.,et al, 2003
Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients
BMJ 326:21, Maas,R.,et al, 2003
Trends in Community Knowledge of the Warning Signs and Risk Factors for Stroke
JAMA 289:343-346, Schneider,A.T.,et al, 2003
New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003
Non-convulsive Status Epilepticus: Usefulness of Clinical Features in Selecting Patients for Urgent EEG
JNNP 74:189-191, Husain,A.M.,et al, 2003
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003
Reversible Postictal MRI Change Mimicking Structural Lesion
Clin Neurol Neurosurg 105:288-290, Hicdonmez, T.,et al, 2003
Generalized Convulsive Status Epilepticus in Creutzfeldt-Jakob Disease
Seizure 12:403-406, Neufeld,M.Y.,et al, 2003
Occipital Seizures Presenting with Bilateral Visual Loss
Neurol India d51:115-116, Hadjikoutis, S. & Sawhney, M., 2003
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Epilepsia Partialis Continua as an Atypical Presentation of Cat Scratch Disease in a Young Adult
Neurol 59:1815-1816, Nowakowsi,G.S. &Katz,A., 2002
Prophylaxis of Menstrual Migraine with Triptans
Neurol 59:1677-1681, Loder,E., 2002
Transient Ischemic Attack
NEJM 347:1687-1692, Johnston,S.C., 2002
Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002
Paresis Acquired in the Intensive Care Unit
JAMA 288:2859-2867, De Jonghe,B.,et al, 2002
Recommendations for the Endovascular Treatment of Intracranial Aneurysms
Stroke 33:2536-2544, Johnston,S.C.,et al, 2002
Infections of Intracardiac Devices
Infect Dis Clin North Am 16:477-505, Karchmer,A.W. &Longworth,D.L., 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002
Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002
Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002